Erector Spinae Block Versus Caudal Block for Perioperative Analgesia in Pediatric Cancer Patients
Comparison of Ultrasound Guided Erector Spinae Block and Ultrasound Guided Caudal for Perioperative Analgesia in Pediatric Cancer Patients Undergoing Nephrectomy Surgeries: a Randomized Controlled Study
1 other identifier
interventional
80
1 country
1
Brief Summary
The study aim to compare ultrasound guided erector spinae plane block versus ultrasound guided caudal block in perioperative analgesia for pediatric cancer patients
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Dec 2021
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 29, 2021
CompletedFirst Posted
Study publicly available on registry
December 10, 2021
CompletedStudy Start
First participant enrolled
December 20, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 26, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
July 29, 2024
CompletedSeptember 24, 2024
January 1, 2024
2.6 years
November 29, 2021
September 22, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
opioid consumption
postoperative morphine consumption
First 24 hours postoperatively
Study Arms (2)
Ultrasound guided erector spinae plane block
EXPERIMENTALUnilateral erector spinae plane block will be performed under ultrasound guidance
Ultrasound guided caudal block
ACTIVE COMPARATORCaudal block will be formed under ultrasound guidance
Interventions
Ultrasound guided erector spinae plane block
Eligibility Criteria
You may qualify if:
- ASA I and II
- Age \>1 and \<12
- patients undergoing nephrectomy surgeries
You may not qualify if:
- patients parental refusal
- local infection at the puncture site
- coagulopathy with INR\> 1.6
- unstable cardiovascular disease
- patients allergic to medication used
- development or mental delay
- impaired liver and renal functions
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Walaa Y Elsabeeny
Cairo, 11796, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Walaa Y Elsabeeny, MD
Assistant Professor of Anesthesia and Pain Management, National Cancer Institute, Cairo University
- PRINCIPAL INVESTIGATOR
Yasmen F Abdelghani, M.Sc
Assistant Lecturer of Anesthesia and Pain Management, National Cancer Institute, Cairo University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor of Anesthesia and Pain management
Study Record Dates
First Submitted
November 29, 2021
First Posted
December 10, 2021
Study Start
December 20, 2021
Primary Completion
July 26, 2024
Study Completion
July 29, 2024
Last Updated
September 24, 2024
Record last verified: 2024-01